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Abstract 
Polyclonal antibodies were raised in rabbits against he C-terminal portion of the rat renal brush-border membrane sodium/phosphate 
cotransporter NaPi-2. Antibody specificity and molecular sizes of proteins related to NaPi-2 were assayed by Western blot analysis. 
Proteins of 40 and 70-75 kDa (p40 and p70) were immunodetected in rat and mouse brush-border membranes and proteins of 72 and 82 
kDa were detected in rabbit. The absence or presence of fl-EtSH in the samples before electrophoresis greatly influenced the 
immunodetection profile of the rat proteins. Since the 40 kDa protein (p40) can only be detected under reducing conditions, it probably 
originates from reduction of disulfide bonds in p70. Tryptic cleavage of p40 and p70 revealed identical protein fragments howing the 
close structural identity of those proteins. Both proteins were more abundant in the outer cortex portion of the rat kidney than in the 
juxtamedullary portion. Furthermore, rats fed a low-phosphate diet for 24 h showed a 20- and 14-fold increase in the amount of p40 and 
p70, respectively, compared to control rats, showing that the adaptation to Pi deprivation by increasing renal phosphate reabsorption is not 
only the result of overproduction of p70, as previously shown, but is also due to the novel p40 which most probably derives from p70. 
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1. Introduction 
Renal reabsorption of inorganic phosphate (Pi) from the 
glomerular filtrate takes place essentially across the brush- 
border membrane (BBM) of the proximal tubule. This 
process, under hormonal and cellular control [1-3], in- 
volves a specific sodium gradient-dependent transport sys- 
tem [4,5]. Phosphate most likely leaves the cell via an 
anion-exchange mechanism located in the basolateral 
membrane [6,7]. 
The recent expression cloning in Xenopus laevis oocytes 
of NaPi-1 [8] and NaPi-6 [9] cDNA from rabbit, NaPi-2 
from rat [10], NaPi-3 from human [10], NaPi-4 from OK 
Abbreviations: ~EtSH, fl-mercaptoethanol; BBM, brush-border 
membrane; HPLC, high performance liquid chromatography; IgG, im- 
munoglobulin G; KLH, keyhole limpet hemocyanin; PAGE, polyacryl- 
amide gel electrophoresis; Pi, inorganic phosphate; PVDF, polyvinylidene 
difluoride. 
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cells [11,12] and NaPi-5 cotransport system from flounder 
[13] constitutes a major step in our understanding of the 
molecular structure, function and regulation of the 
sodium/phosphate cotransporter. Since all systems except 
NaPi-1 seem to belong to the same family of cotrans- 
porters, it has been suggested that NaPi-1 be designated 
type I and the other systems be called type II (NaPi-2, 3, 4, 
5 and 6) [3,9]. Also, according to its predicted molecular 
mass, NaPi-1 is a smaller protein (~ 52 kDa) than type II 
systems (~ 70 kDa) and shows very little homology with 
them [10,14]. In vitro translation experiments have demon- 
strated that both types of NaPi cotransporters are N-glyco- 
sylated [8,10]. In addition, a recent study has identified two 
sites of N-glycosylation (Asn-298 and Asn-328) on an 
extracellular domain of NaPi-2 using site-directed mutage- 
nesis [ 15]. According to this report, glycosylation of NaPi-2 
does not appear to be essential for sodium/phosphate 
cotransport. Another point of comparison between both 
types of cotransport systems is that type II systems have 
been shown to play a role in the adaptive response to 
low-P i diet [9,16] but NaPi-I does not appear to be in- 
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volved [9,14,17]. Immunodetection studies have shown 
that NaPi-l-related proteins are present predominantly in
the juxtamedullary portion of rat kidney cortex compared 
to the superficial cortex [17,18]. 
Recent studies have demonstrated that the level of 
NaPi-2-related mRNA and protein is reduced by 50% in 
the X-linked Hyp mouse, an animal model for hypophos- 
phatemic vitamin D-resistant rickets in humans and ani- 
mals [19-21]. This reduction is correlated with lower 
phosphate transport in BBM vesicles isolated from Hyp 
mice [22]. 
In the present study, we identified and partly charac- 
terized NaPi-2-related proteins from the kidney's proximal 
tubule of rat, mouse and rabbit. These proteins were 
analyzed with the Western blot technique using polyclonal 
antibodies raised against he C-terminal portion of the rat 
NaPi-2 protein as deduced from the nucleotide sequence of 
its cloned cDNA [10]. A novel protein of 40 kDa (p40) 
was detected and appears to derive from a protein of 
70-75 kDa (p70), which is closer to the predicted molecu- 
lar mass of 68.7 kDa deduced from the cDNA [10]. Both 
proteins possessed similar physico-chemical properties and 
p40 was regulated in the same fashion as p70 during 
low-phosphate diet, suggesting that p40 may play an im- 
portant role in the regulation of renal sodium/phosphate 
cotransport. 
over the cortex homogenate. Cytosol was prepared by 
differential centrifugation at 4°C. After disruption of the 
tissue in a Potter tissue homogenizer (Braun, Melsungen, 
Germany), intact cells were removed by centrifugation at
3000 × g for 10 min. The supernatant was then cen- 
trifuged at 100000 × g to yield a pellet enriched in micro- 
somes and a supernatant containing the cytosolic fraction. 
2.2. Peptide synthesis 
The fifteen-amino acid peptide CPRLALPAHHNATRL 
was synthesized with an Applied Biosystems automated 
peptide synthesizer model 431A (Mississauga, Ont.) using 
Fmoc (9-fluoronyl-methyloxycarbonyl) chemistry follow- 
ing the recommendations of the manufacturer. This peptide 
corresponds to the 14-amino acid C-terminal portion of the 
rat sodium/phosphate symporter as deduced from the 
nucleotide sequence of the cloned NaPi-2 gene [10] to 
which an N-terminal cysteine residue was added to allow 
coupling of the peptide to a carrier protein. The peptide 
was purified on a semi-preparative Vydac C18 high perfor- 
mance liquid chromatography (HPLC) column (Hesperia, 
CA) and its identity was confirmed by fast atom bombard- 
ment mass spectroscopy. 
2.3. Immunization 
2. Materials and methods 
2.1. Membrane preparations and cell fractionation 
Sixteen-week-old male New Zealand rabbits (2 kg) and 
2-month-old male Sprague-Dawley rats (300-350 g) were 
purchased from Charles River (St-Constant, Que.); beef 
kidneys were obtained from a local abattoir; mice were 
purchased from Jackson Laboratory (Bar Harbor, ME); and 
partially purified plasma membranes from OK cells were 
kindly provided by Dr. Andrew Baines (Toronto, Canada). 
In order to examine the effect of phosphate deprivation, 
rats were fed either a low-phosphate (No. 86128) or a 
standard (No. 86129) diet from Teklad (Madison, WI) 
containing 0.03% (w/w) or 1% (w/w) phosphate for 3 
days. Brush-border membrane vesicles were prepared from 
outer and juxtamedullary cortex according to the method 
of Booth and Kenny [23]. The final pellet containing 
purified brush-border membranes was resuspended in 300 
mM mannitol/20 mM Hepes/Tris, pH 7.5, and the fol- 
lowing protease inhibitors: chymostatin A (10 /xg/ml), 
bacitracin (10 /xg/ml), pepstatin (10 /zg/ml) and apro- 
tinin (1.85 /xg/ml). The outer cortex was defined as the 
zone extending from the surface of the kidney to the 
middle of the cortex, and juxtamedullary cortex as the 
other half of the cortex. The purity of the membrane 
preparations was evaluated by measuring alkaline phos- 
phatase activity [24] which was enriched 10- to 15-fold 
The HPLC-purified peptide was coupled to keyhole 
limpet hemocyanin (KLH) (Pierce, Rockford, IL) through 
the free sulfhydryl group of its cysteine residue with MBS 
(Pierce) as described by Mumby and Gilman [25]. On day 
0, rabbits were injected subcutaneously at 2 sites on the 
back and intramuscularly at2 sites on the rear hinds with 
400 p,g of the KLH-coupled peptide mixed homoge- 
neously with Freund's complete adjuvant (Pierce) in a 1:1 
volume ratio. A booster injection of antigen was adminis- 
tered on day 14 using Freund's incomplete adjuvant. The 
final injection (day 26) consisted of 400 /xg of KLH-cou- 
pied peptide adsorbed to aluminum hydroxide (Imject TM 
Alum, Pierce) administered intraperitoneally at two sites in 
the lower abdomen. The rabbits were bled 33 days after 
the final injection. The blood was allowed to coagulate at 
room temperature for 1 h and stored overnight at 4°C to 
allow the clot to retract. The clot was discarded and the 
serum was collected after blood cells were removed by 
centrifugation at ~ 1000 × g for 10 min. 
2.4. Antibody purification 
The immunoglobulin G (IgG) of the serum (adjusted to 
pH 8.6 with Tris/HC1) was purified on a 5-ml HiTrap 
protein A fast protein liquid chromatography column 
(Pharmacia, Dorval, Que.) equilibrated with 50 mM 
Tris/HCl, pH 8.6. The column was washed extensively 
with the same buffer and the IgG was eluted with 100 mM 
citrate, pH 3. The fractions (1 ml) were collected in tubes 
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containing 100 /~1 of 1 M Tris/HC1, pH 9, to neutralize 
the citrate. The antibodies were further purified by affinity 
chromatography on a peptide-Sepharose column (2 ml) 
prepared as described by Mumby and Gilman [25] and 
equilibrated with 100 mM NaC1, 20 mM Tris/HC1, pH 7.5 
(buffer A). After extensive washing with the same buffer, 
the antibodies were eluted from the column with 0.2 M 
glycine, pH 2.2. The fractions were collected as mentioned 
above for the protein A column. Neutralized fractions that 
contained protein, as determined by absorbance at280 nm, 
were pooled and dialyzed overnight against buffer A. 
2.5. Western blot analysis 
Sodium dodecyl sulfate polyacrylamide gel elec- 
trophoresis (SDS-PAGE) was performed with a Mini-Pro- 
tean II (Bio-Rad, Mississauga, Ont.) electrophoresis appa- 
ratus and the Laemmli buffer system [26]. The separating 
gel contained 7.5% (w/v)  acrylamide/bis-acrylamide 
(29.1:0.9). Unless indicated otherwise, prior to elec- 
trophoresis, the samples were mixed with sample buffer 
containing a final concentration of 1.0% (w/v)  SDS and 
2.5% (v/v)  fl-EtSH, without boiling. Electrophoresis was 
carried out at a constant voltage of 120 V for about 1.5 h. 
Unless indicated otherwise, each well contained 12 /xg of 
protein. Molecular mass determinations were based on a 
calibration curve prepared with protein standards (Bio- 
Rad). 
Following electrophoresis, the gels were equilibrated in
transfer buffer (10% (v/v)  methanol, 25 mM Tris, 192 
mM glycine, pH 8.3) for 15 rain. The proteins were 
transferred onto polyvinylidene difluoride (PVDF) microp- 
orous (0.45-#m pore diameter) membranes (Millipore, 
Mississauga, Ont.) by electroelution i a Mini Trans-Blot 
electrophoresis transfer cell (Bio-Rad) at a constant volt- 
age of 100 V for 3 h at 4°C. The non-specific binding sites 
on PVDF membranes were blocked by overnight incuba- 
tion in 150 mM NaC1, 0.05% (w/v)  Tween 20, 0.1% 
(w/v)  bovine serum albumin and 50 mM Tris/HCl, pH 
7.0 (buffer B) containing 5% (w/v)  powdered milk, at 
4°C. The membranes were washed three times by gentle 
agitation in buffer B for 10 rain and incubated for 1 h with 
a 1/6000 dilution of the anti-peptide antibody in buffer B. 
The membranes were then washed three more times in 
buffer B and incubated for 1 h with a 1/1000 dilution of 
anti-rabbit IgG horseradish peroxidase-linked whole anti- 
body from donkey (Amersham, Oakville, Ont.) in buffer 
B. The membranes were finally washed three times for l0 
rain in buffer B and labelled antigens were revealed with 
enhanced chemiluminescence (ECL) Western blotting so- 
lutions (Amersham) following the recommendations of the 
manufacturer. The membranes were exposed for appropri- 
ate times to Fuji or Kodak films which were preflashed 
with a Sensitize flashgun unit (Amersham). The films were 
developed with a Mini-Med/90 X-ray film processor (AFP 
Imaging, Elmsford, NY). The X-ray films were analyzed 
with an Ultroscan XL laser densitometer (Pharmacia). 
2.6. Tryptic cleavage 
Brush-border membrane proteins (250/xg) were applied 
on a two-well 1-mm gel containing 7.5% (w/v)  acryl- 
amide/bis-acrylamide (29.1:0.9) and resolved using SDS- 
PAGE. Prior to electrophoresis, the samples were mixed 
with sample buffer at a final concentration f 1.0% (w/v)  
SDS and 2.5% (v/v)  fl-EtSH, without boiling. Elec- 
trophoresis was carried out at a constant voltage of 100 V 
for about 1.5 h. Following their separation, proteins of 40 
and 70 kDa were cut from the gel and homogenized using 
a Potter tissue homogenizer (Braun, Melsungen, Germany). 
Both samples were treated as described by Cleveland et al. 
[27]. Protein samples were deposited on a second SDS- 
PAGE gel (1.5 ram) containing 15% (w/v)  
acrylamide/bis-acrylamide (29.1:0.9) and before starting 
electrophoresis, 1 /~g trypsin (12.7 U) (Sigma) was added 
into each sample well. Electrophoresis, Westem blot and 
immunodetection procedures were carried out as previ- 
ously described. 
3. Results 
Polyclonal antibodies directed against he 14-amino acid 
C-terminal portion of the cloned rat renal brush-border 
membrane sodium/phosphate cotransporter NaPi-2 [10] 
were raised in rabbits, affinity-purified and used to deter- 
mine the presence of related proteins in rat, mouse, rabbit 








Fig. 1. Immunodetection of renal brush-border membrane proteins from 
rat, mouse, rabbit, beef, as well as in partially purified plasma membranes 
from OK cells using polyclonal ntibodies directed against the rat renal 
sodium/phosphate cotransporter NaPi-2. Brush-border membrane pro- 
teins were resolved by SDS-PAGE using 7.5% polyacrylamide gels. 
Immunoblots were performed asdescribed under Section 2and antibody 
binding was detected using donkey horseradish peroxidase-linked anti- 
rabbit IgG antibodies. Labelled antigens were revealed by autoradiog- 
raphy with ECL Western blotting solutions. Comparable data were ob- 
tained in three independent xperiments performed in duplicate. 
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Fig. 2. Effect of /3-mercaptoethanol o  the immunodetection of rat renal 
brnsh-border membrane proteins. Samples were prepared either in the 
absence ( - )  or presence (+) of /3-EtSH. Proteins were analyzed as 
described in the legend of Fig. 1. Comparable data were obtained in five 
independent experiments. 
plasma membranes from OK cells (Fig. 1). Western blots 
of rat and mouse BBM revealed proteins of 40, 70-75 
(designated p40 and p70), 116 and 176 kDa. When 10 -6 
M of the antigenic peptide was added during incubation 
with the antibodies, those rat proteins were not detected 
(not shown). The 176-kDa protein was more strongly 
detected in mouse than rat BBM. However, detection of 
both 116- and 176-kDa proteins was not systematically 
observed in all BBM preparations and therefore no further 
analysis of those proteins was pursued. Proteins of 72 and 
82 kDa were detected in BBM prepared from rabbit kidney 
cortex. No protein could be detected in BBM from beef 
and in plasma membranes purified from OK ceils. 
The influence of /3-mercaptoethanol (/3-EtSH) on the 
immunodetection profile of rat BBM proteins was investi- 
gated (Fig. 2). Immunoblots of BBM proteins were ana- 
lyzed after electrophoresis of samples which had been 
prepared either in the absence or presence of /3-EtSH. 
Exclusion of the reducing agent from the samples before 
electrophoresis resulted in Western blots where p40 was 
absent while detection of p70 was enhanced. Under these 
non-reducing conditions, an additionnal protein of about 
180 kDa (p180) was also detected. Addition of /3-EtSH to 
the samples before electrophoresis resulted in Western 
blots where only 1340 and p70 were immunodetected. 
Boiling of the samples prior to electrophoresis had no 
effect on the immunodetection of any of these proteins 
(not shown). To further study p40, the addition of/3-EtSH 
to protein samples before electrophoresis was used in 
following Western blot experiments. 
To investigate the relationship between the rat p40 and 
p70 proteins, we performed limited trypsin proteolysis on 
each of these proteins, following their separation by SDS- 
PAGE. After enzymatic cleavage, eight fragments were 
obtained from p70, identical to those found in the p40 
fragment pattern, demonstrating that these proteins are 
very similar in their amino acid sequence (Fig. 3). 
The presence of p40 and p70 proteins was investigated 
in outer cortical and juxtamedullary fractions from rat 
Fig. 3. Comparison ofpeptide fragments obtained by tryptic leavage of 
BBM rat 40- and 70-kDa proteins. Proteins of 40 and 70 kDa were 
separated and cut from a first gel (7.5% polyacrylamide); both gel slices 
were homogenized and loaded on a second gel (15% polyacrylamide) in 
the presence (Digested) or absence (Ctl) of 1 /zg trypsin (12.7 U) as 
described under Section 2. Proteins were analyzed as described in the 
legend of Fig. 1. Both digestions were performed in triplicate. Compara- 
ble data were obtained in two independent experiments performed in
triplicate. 
kidney cortex (Fig. 4). Both proteins were enriched in the 
BBM portion compared to the homogenate where they are 
present in a much smaller proportion of total protein. The 
detection of these proteins in the brush-border membrane 
was 7- to 8-fold stronger in the outer cortex region than in 
the juxtamedullary region. These proteins were absent 
from the cytosolic fraction. 
The expression of NaPi-2 was studied under a condition 
previously shown to alter phosphate reabsorption. Renal 
adaptation to chronic dietary phosphate deprivation is well 
known to involve an adaptive increase of sodium/phos- 
phate cotransport in brush-border membranes from the 
proximal tubule [28,29]. Under these low dietary phos- 
phate conditions, the initial rate of Na÷-dependent phos- 
phate transport into vesicles is increased 3- to 4-fold [17]. 
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Fig. 4. Western blot analysis of fractions from rat kidney cortex. Proteins 
from the cell homogenate (HOMO), brush-border membrane (BBM) and 
cytosolic (CYT) fractions from outer (O) and juxtamedullary (J) cortex 
were analyzed as described inthe legend of Fig. 1. Comparable data were 
obtained in three independent experiments performed in duplicate. 
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Fig. 5. Effect of a low-phosphate diet on the immunodetection of p40 and 
p70 in rat brush-border membranes. BBM were isolated from the outer 
cortex portion of rats either fed a low-phosphate diet (LPD) for 6, 24, 48 
and 72 h (A), or submitted to a LPD for 72 h and then given a normal 
diet (B). In B, the hours indicated represent the time after the LPD was 
stopped. There was a control (Ctl) for each group of rats. Proteins were 
analyzed as described in the legend of Fig. 1 and the resulting relative 
absorbance (treated rats/control rats) was plotted as a function of the 
time of treatment (C). Comparable data were obtained in three indepen- 
dent experiments. 
The low dietary phosphate intake led to a maximum 20- 
and 14-fold increase in the intensity of the immunolabelled 
p40 and p70 proteins, respectively (Fig. 5A and C) after 24 
to 48 h. Upon return to a normal diet, p40 and p70 levels 
decreased to control evels within 24 to 48 h (Fig. 5B and 
C). 
4. Discussion 
To study the type II sodium/phosphate symporter, 
polyclonal antibodies were raised against a synthetic pep- 
tide corresponding tothe 14-amino acid C-terminal portion 
of the recently cloned rat kidney cortex sodium/phosphate 
cotransporter designated NaPi-2 [10]. This C-terminal seg- 
ment was chosen because hydropathy analysis of the amino 
acid sequence of NaPi-2 [3,10,30] according to Kyte and 
Doolittle [31] suggests that it is fairly hydrophilic and 
predicted to be exposed. The affinity-purified antibodies 
were used in Western blot experiments to identify 
immunoreactive membrane proteins. Proteins of 40 and 
70-75 kDa (p40 and p70) were specifically detected by 
the antibodies in membranes obtained from rat and mouse 
kidney cortex. Addition of protease inhibitors during BBM 
purification or incubation of purified BBM with or without 
protease inhibitors were without any effect on the detec- 
tion of p70 and p40, indicating that 1940 is not a degrada- 
tion artifact occurring during membrane isolation. The 
apparent molecular mass of 70-75 kDa (p70) is in good 
agreement with that calculated from the amino acid se- 
quence of non-glycosylated NaPi-2 which is 68.7 kDa [10], 
but not the p40 which most probably derives from p70. 
Similar reports using polyclonal antibodies directed against 
the deduced N- and C-terminal amino acid sequences of 
NaPi-2 have demonstrated the detection of proteins of 
apparent molecular masses of ~ 80-90 kDa in rat BBM 
and ~ 80-110 kDa in cRNA-injected oocytes [15,32]. Our 
antibodies cross-reacted with rabbit BBM proteins of 72 
and 82 kDa because the C-terminal sequence of the rat 
NaPi-2 cotransporter [10] is identical to the one from 
NaPi-6 type II cotransporter from rabbit [9]. The apparent 
molecular masses of these two proteins is in good agree- 
ment with that calculated from the amino acid sequence of 
non-glycosylated NaPi-6 which is 69.4 kDa [9]. The reac- 
tivity of our antibodies with rat, mouse and rabbit BBM 
proteins indicates that this carrier possesses imilar epi- 
topes in these species. The absence of detected proteins 
from partially purified OK cell plasma membranes served 
as a negative control since the type II sodium/phosphate 
cotransporter cloned from this species (NaPi-4) does not 
possess the same antigenic C-terminal sequence as NaPi-2 
from rat [12]. No protein related to NaPi-2 could be 
detected in beef BBM using these antibodies, but the 
C-terminal portion of the recently cloned type II sodium- 
dependent phosphate cotransporter from the bovine renal 
epithelial cell line NBL-I shares only 3 identical amino 
acids with the rat renal NaPi-2 cotransporter [33]. 
The detection of p180 when fl-EtSH is omitted from 
samples before electrophoresis uggests that the phosphate 
transporter may be formed of subunits linked together with 
disulfide bonds to constitute a protein complex, as previ- 
ously suggested for NaPi-1 [17]. A few studies using the 
radiation inactivation technique have reported high molec- 
ular mass proteins for the renal sodium/phosphate sym- 
porter [34-36]. Thiol oxidation was also suggested to be 
involved in the regulation of Pi uptake by BBM [37]. 
Furthermore p40, which can only be detected under educ- 
ing conditions, probably originates from reduction of disul- 
fide bonds in p70. However, the effects of reduction on 
NaPi-2-related proteins are still unclear and deserve further 
study. 
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The eight' identical fragments obtained for both p40 and 
p70 after tryptic cleavage demonstrate the very close struc- 
tural relation between these proteins. These fingerprinting 
experiments show that both proteins possess a common 
portion of their amino acid chains that contains the same 
tryptic cleavage sites. This may suggest that the regulation 
of this cotransport could involve a step where the 70 kDa 
protein is specifically cleaved to give a 40 kDa protein. 
Also, the outer cortex BBM co-localization of both 
proteins (p40 and p70) agrees with recent findings ob- 
tained using immunohistochemistry [38]. Thus, as men- 
tioned above, this contributes to the possibility that p40 
could derive from p70. 
Adaptation to Pi restriction is dependent on de novo 
protein synthesis but it is still unclear whether the proteins 
involved are sodium/phosphate cotransporters or other 
proteins playing a role in the regulation of this transport. In 
this study, a 20- and 14-fold increase in the amount of 
NaPi-2-related proteins detected (p40 and p70, respec- 
tively) was observed for BBM of rats submitted to a 
low-phosphate diet for 24 to 48 h. The sodium/phosphate 
cotransport was 3- to 4-fold higher than controls (results 
not shown). The increase in NaPi-2 related proteins thus 
appears to be associated with an adaptive increase in 
sodium/phosphate cotransport in response to a low-P i diet. 
This is the first report showing the apparent involvement 
of a 40-kDa protein (p40) in this type of regulation. 
However, the reason why the increase in p40 and p70 
expression under low-phosphate conditions i  much higher 
than the increase in transport remains unknown, but sug- 
gests a possible pool of inactive transporters egulated to 
remain metabolically quiescent. A low ratio BBM vesi- 
cles/leaflets could also be responsible for these discrepan- 
cies: the immunodetection f NaPi-2 does not distinguish 
between BBM vesicles and leaflets, but sodium/phosphate 
cotransport assays can only be accomplished through BBM 
vesicles. Previous reports have demonstrated by Northern 
and Western blot analysis an increase of NaPi-2-related 
mRNA in the kidney cortex of rats fed a low-phosphate 
diet compared to control rats [16,38]. Furthermore, the 
injection of mRNA from rats adapted to a low-P i diet into 
oocytes resulted in a higher expression of sodium/phos- 
phate cotransport [30]. In contrast, previous studies have 
shown that a low-phosphate diet does not affect the level 
of expression of the type I (NaPi-1) renal sodium/phos- 
phate cotransporter [9,14,17]. 
In conclusion, the proteins detected in rat, rabbit and 
mouse possess an epitope sufficiently similar to the C- 
terminal region of NaPi-2 to be recognized by this anti- 
body. The rat and mouse BBM introduce, in addition to 
p70, an unexpected p40 possessing similar physico-chem- 
ical properties. Both proteins present an adaptive response 
to a low-phosphate diet. This study reports evidence sug- 
gesting that along with p70, p40 may play an important 
role in the renal sodium/phosphate cotransport and its 
regulation. 
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